Type i and II endometrial cancers: Have they different risk factors?

Veronica Wendy Setiawan, Hannah P. Yang, Malcolm C. Pike, Susan E. McCann, Herbert Yu, Yong Bing Xiang, Alicja Wolk, Nicolas Wentzensen, Noel S. Weiss, Penelope M. Webb, Piet A. Van Den Brandt, Koen Van De Vijver, Pamela J. Thompson, Brian L. Strom, Amanda B. Spurdle, Robert A. Soslow, Xiao Ou Shu, Catherine Schairer, Carlotta Sacerdote, Thomas E. RohanKim Robien, Harvey A. Risch, Fulvio Ricceri, Timothy R. Rebbeck, Radhai Rastogi, Jennifer Prescott, Silvia Polidoro, Yik Yung Park, Sara H. Olson, Kirsten B. Moysich, Anthony B. Miller, Marjorie L. McCullough, Rayna K. Matsuno, Anthony M. Magliocco, Galina Lurie, Lingeng Lu, Jolanta Lissowska, Xiaolin Liang, James V. Lacey, Laurence N. Kolonel, Brian E. Henderson, Susan E. Hankinson, Niclas Hakansson, Marc T. Goodman, Mia M. Gaudet, Montserrat Garcia-Closas, Christine M. Friedenreich, Jo L. Freudenheim, Jennifer Doherty, Immaculata De Vivo, Kerry S. Courneya, Linda S. Cook, Chu Chen, James R. Cerhan, Hui Cai, Louise A. Brinton, Leslie Bernstein, Kristin E. Anderson, Hoda Anton-Culver, Leo J. Schouten, Pamela L. Horn-Ross

Research output: Contribution to journalArticle

300 Scopus citations

Abstract

Purpose Endometrial cancers have long been divided into estrogen-dependent type I and the less common clinically aggressive estrogen-independent type II. Little is known about risk factors for type II tumors because most studies lack sufficient cases to study these much less common tumors separately. We examined whether so-called classical endometrial cancer risk factors also influence the risk of type II tumors. Patients and Methods Individual-level data from 10 cohort and 14 case-control studies from the Epidemiology of Endometrial Cancer Consortium were pooled. A total of 14,069 endometrial cancer cases and 35,312 controls were included. We classified endometrioid (n = 7,246), adenocarcinoma not otherwise specified (n = 4,830), and adenocarcinoma with squamous differentiation (n = 777) as type I tumors and serous (n = 508) and mixed cell (n = 346) as type II tumors. Results Parity, oral contraceptive use, cigarette smoking, age at menarche, and diabetes were associated with type I and type II tumors to similar extents. Body mass index, however, had a greater effect on type I tumors than on type II tumors: odds ratio (OR) per 2 kg/m2 increase was 1.20 (95% CI, 1.19 to 1.21) for type I and 1.12 (95% CI, 1.09 to 1.14) for type II tumors (Pheterogeneity > .0001). Risk factor patterns for high-grade endometrioid tumors and type II tumors were similar. Conclusion The results of this pooled analysis suggest that the two endometrial cancer types share many common etiologic factors. The etiology of type II tumors may, therefore, not be completely estrogen independent, as previously believed.

Original languageEnglish (US)
Pages (from-to)2607-2618
Number of pages12
JournalJournal of Clinical Oncology
Volume31
Issue number20
DOIs
StatePublished - Jul 10 2013

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y. B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., Van Den Brandt, P. A., Van De Vijver, K., Thompson, P. J., Strom, B. L., Spurdle, A. B., Soslow, R. A., Shu, X. O., Schairer, C., Sacerdote, C., ... Horn-Ross, P. L. (2013). Type i and II endometrial cancers: Have they different risk factors? Journal of Clinical Oncology, 31(20), 2607-2618. https://doi.org/10.1200/JCO.2012.48.2596